相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms
Michael A. P. Bloomfield et al.
BIOLOGICAL PSYCHIATRY (2014)
Changes in CB1 and CB2 receptors in the post- mortem cerebellum of humans affected by spinocerebellar ataxias
Carmen Rodriguez-Cueto et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Stress-Induced Dopamine Response in Subjects at Clinical High Risk for Schizophrenia with and without Concurrent Cannabis Use
Romina Mizrahi et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Impact of Prolonged Cannabinoid Excretion in Chronic Daily Cannabis Smokers' Blood on Per Se Drugged Driving Laws
Mateus M. Bergamaschi et al.
CLINICAL CHEMISTRY (2013)
Striatal D2/D3 receptor availability is inversely correlated with cannabis consumption in chronic marijuana users
Daniel S. Albrecht et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Striatal dopamine release in schizophrenia comorbid with substance dependence
J. L. Thompson et al.
MOLECULAR PSYCHIATRY (2013)
Cocaine dependence: a fast-track for brain ageing?
K. D. Ersche et al.
MOLECULAR PSYCHIATRY (2013)
Structural and Functional Imaging Studies in Chronic Cannabis Users: A Systematic Review of Adolescent and Adult Findings
Albert Batalla et al.
PLOS ONE (2013)
Delta-9-Tetrahydrocannabinol-Induced Dopamine Release as a Function of Psychosis Risk: 18F-Fallypride Positron Emission Tomography Study
Rebecca Kuepper et al.
PLOS ONE (2013)
Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET study
Claire Leroy et al.
ADDICTION BIOLOGY (2012)
Addiction Circuitry in the Human Brain
Nora D. Volkow et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
Dopamine Release in Chronic Cannabis Users: A [11C]Raclopride Positron Emission Tomography Study
Nina B. L. Urban et al.
BIOLOGICAL PSYCHIATRY (2012)
Higher Binding of the Dopamine D3 Receptor-Preferring Ligand [11C] -(+)-Propyl-Hexahydro-Naphtho-Oxazin in Methamphetamine Polydrug Users: A Positron Emission Tomography Study
Isabelle Boileau et al.
JOURNAL OF NEUROSCIENCE (2012)
History of cannabis use is not associated with alterations in striatal dopamine D-2/D-3 receptor availability
Paul R. A. Stokes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Cannabis-Related Stroke: Case Series and Review of Literature
Niranjan N. Singh et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2012)
Decreased dopamine activity predicts relapse in methamphetamine abusers
G. J. Wang et al.
MOLECULAR PSYCHIATRY (2012)
Chronic Δ9-Tetrahydrocannabinol Exposure Induces a Sensitization of Dopamine D2/3 Receptors in the Mesoaccumbens and Nigrostriatal Systems
Nathalie Ginovart et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Cannabis-Dependence Risk Relates to Synergism between Neuroticism and Proenkephalin SNPs Associated with Amygdala Gene Expression: Case-Control Study
Didier Jutras-Aswad et al.
PLOS ONE (2012)
Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study
Emma Barkus et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Imaging dopamine receptors in humans with [C-11]-(+)-PHNO: Dissection of D3 signal and anatomy
Andri C. Tziortzi et al.
NEUROIMAGE (2011)
Cannabis Use, Ischemic Stroke, and Multifocal Intracranial Vasoconstriction A Prospective Study in 48 Consecutive Young Patients
Valerie Wolff et al.
STROKE (2011)
Genetically determined dopamine availability predicts disposition for depression
Andrea Felten et al.
BRAIN AND BEHAVIOR (2011)
Dopamine in Motivational Control: Rewarding, Aversive, and Alerting
Ethan S. Bromberg-Martin et al.
NEURON (2010)
Abnormal cerebellar morphometry in abstinent adolescent marijuana users
Krista Lisdahl Medina et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2010)
Can recreational doses of THC produce significant dopamine release in the human striatum?
Paul R. A. Stokes et al.
NEUROIMAGE (2009)
Looking for the role of cannabinoid receptor heteromers in striatal function
Sergi Ferre et al.
NEUROPHARMACOLOGY (2009)
Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum
Matthijs G. Bossong et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Stress-related factors in cannabis use and misuse: Implications for prevention and treatment
Scott M. Hyman et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2009)
Differences in regional blood volume during a 28-day period of abstinence in chronic cannabis smokers
Jennifer T. Sneider et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers.: A combined neurochemical and behavioral analysis
Daniel Marcellino et al.
NEUROPHARMACOLOGY (2008)
Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography
Serge Sevy et al.
PSYCHOPHARMACOLOGY (2008)
The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients
Anne Ducros et al.
BRAIN (2007)
Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement
Nora D. Volkow et al.
JOURNAL OF NEUROSCIENCE (2007)
Amphetamine-induced dopamine release: Markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine
Diana Martinez et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
In vitro characterisation of the high affinity D2/D3 dopamine agonist (+)PhNO
Christine Parker et al.
NEUROIMAGE (2006)
Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum
D Martinez et al.
BIOLOGICAL PSYCHIATRY (2005)
Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons
M Andersson et al.
JOURNAL OF NEUROSCIENCE (2005)
The role of central dopamine D3 receptors in drug addiction:: a review of pharmacological evidence
CA Heidbreder et al.
BRAIN RESEARCH REVIEWS (2005)
Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo Imaging of the dopamine D2 high-affinity state with positron emission tomography
AA Wilson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: A mechanism for receptor cross-talk?
CS Kearn et al.
MOLECULAR PHARMACOLOGY (2005)
Cerebrovascular perfusion in marijuana users during a month of monitored abstinence
RI Herning et al.
NEUROLOGY (2005)
Cerebellar infarction in adolescent males associated with acute marijuana use
T Geller et al.
PEDIATRICS (2004)
Immunohistochemical localization of cerebrovascular cannabinoid CB1 receptor protein
JC Ashton et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2004)
Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma
ND Volkow et al.
PSYCHOPHARMACOLOGY (2003)
Escalation of drug use in early-onset cannabis users vs co-twin controls
MT Lynskey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain
N Tzourio-Mazoyer et al.
NEUROIMAGE (2002)
Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: Therapeutic implications
ND Volkow et al.
SYNAPSE (2002)
Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria
WC Drevets et al.
BIOLOGICAL PSYCHIATRY (2001)
Cannabinoid and dopamine interaction in rodent brain: effects on locomotor activity
JP Meschler et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2000)
Breath carbon monoxide as an indication of smoking habit
ET Middleton et al.
CHEST (2000)
分享论文
